Cargando…
Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response
BACKGROUND: Specialized proresolution molecules (SPMs) halt the transition to chronic pathogenic inflammation. We aimed to quantify serum levels of pro- and anti-inflammatory bioactive lipids in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients, and to identify potential relation...
Autores principales: | Turnbull, James, Jha, Rakesh R, Ortori, Catherine A, Lunt, Eleanor, Tighe, Patrick J, Irving, William L, Gohir, Sameer A, Kim, Dong-Hyun, Valdes, Ana M, Tarr, Alexander W, Barrett, David A, Chapman, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755389/ https://www.ncbi.nlm.nih.gov/pubmed/34979019 http://dx.doi.org/10.1093/infdis/jiab632 |
Ejemplares similares
-
Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
por: Han, Yong-Hyun, et al.
Publicado: (2021) -
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022) -
Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases
por: Tang, Shi, et al.
Publicado: (2018) -
The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids
por: Vijay, Amrita, et al.
Publicado: (2021) -
A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota
por: Li, Chenwen, et al.
Publicado: (2019)